Wells Fargo & Company Replimune Group, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Replimune Group, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 38,250 shares of REPL stock, worth $550,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,250

Previous 29,801 28.35%

Holding current value

$550,035

Previous $268,000 56.34%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$8.09 - $11.23 $68,352 - $94,882	8,449 Added 28.35%	38,250 $419,000
Q2 2024 Aug 13, 2024	BUY	$5.01 - $9.46 $17,049 - $32,192	3,403 Added 12.89%	29,801 $268,000
Q1 2024 May 10, 2024	BUY	$6.87 - $9.31 $27,541 - $37,323	4,009 Added 17.91%	26,398 $215,000
Q4 2023 Feb 09, 2024	SELL	$6.75 - $16.18 $156,384 - $374,858	-23,168 Reduced 50.85%	22,389 $188,000
Q3 2023 Nov 13, 2023	BUY	$15.96 - $22.18 $89,503 - $124,385	5,608 Added 14.04%	45,557 $779,000
Q2 2023 Aug 15, 2023	SELL	$15.65 - $24.1 $68,609 - $105,654	-4,384 Reduced 9.89%	39,949 $927,000
Q1 2023 May 12, 2023	BUY	$17.48 - $29.09 $773,559 - $1.29 Million	44,254 Added 56017.72%	44,333 $782,000
Q4 2022 Feb 13, 2023	SELL	$17.09 - $27.91 $7,485 - $12,224	-438 Reduced 84.72%	79 $2,000
Q3 2022 Nov 14, 2022	SELL	$15.6 - $21.15 $6,910 - $9,369	-443 Reduced 46.15%	517 $9,000
Q2 2022 Aug 12, 2022	SELL	$13.32 - $19.98 $21,724 - $32,587	-1,631 Reduced 62.95%	960 $17,000
Q1 2022 May 16, 2022	SELL	$15.24 - $29.75 $153,893 - $300,415	-10,098 Reduced 79.58%	2,591 $44,000
Q4 2021 Feb 14, 2022	BUY	$25.43 - $34.25 $321,969 - $433,639	12,661 Added 45217.86%	12,689 $343,000
Q2 2021 Aug 16, 2021	SELL	$28.5 - $39.37 $769,728 - $1.06 Million	-27,008 Reduced 99.9%	28 $1,000
Q1 2021 May 13, 2021	SELL	$30.22 - $45.57 $560,611 - $845,369	-18,551 Reduced 40.69%	27,036 $825,000
Q4 2020 Feb 09, 2021	BUY	$23.5 - $52.65 $747,605 - $1.67 Million	31,813 Added 230.96%	45,587 $1.74 Million
Q3 2020 Nov 05, 2020	SELL	$18.85 - $27.0 $68,934 - $98,739	-3,657 Reduced 20.98%	13,774 $317,000
Q2 2020 Aug 13, 2020	BUY	$9.76 - $25.95 $82,676 - $219,822	8,471 Added 94.54%	17,431 $433,000
Q1 2020 May 14, 2020	BUY	$8.9 - $19.08 $79,744 - $170,956	8,960 New	8,960 $89,000

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $709M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Replimune Group, Inc. Transaction History